The offering closed on May 5, 2026, and the large dilution will likely weigh on the stock. Monitor for potential further downside as the market absorbs the new shares. Clinical-stage biotech with no revenue; focus on upcoming data readouts.
Price Chart
Executive Summary
Aura Biosciences closed an underwritten public offering of 46.1M shares and 3.8M pre-funded warrants at $6.00 per share, raising gross proceeds of ~$299.4M. This represents massive dilution for existing shareholders in a clinical-stage biotech with no approved products.
Key Financial Metrics
Key Facts
- Gross proceeds of approximately $299.4 million
- Sold 46,099,650 shares of common stock and pre-funded warrants for 3,800,000 shares
- Public offering price of $6.00 per share
- Underwriters exercised option to purchase additional shares
- Offering closed on May 5, 2026
Financial Impact
Gross proceeds $299.4M; significant dilution of ~50%+ based on pre-offering market cap of $536M
Risk Factors
- Dilution of existing shareholders
- Clinical trial risk
- Cash burn rate
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3288377 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 5w ago | Institutional Cluster | $6.45 $6.56 | ▲ +1.71% | ▲ +2.27% | $6.26 (−2.95%) |
Aug 21, 2026 9w ago | EFFECT | $7.80 $6.36 | ▲ +18.46% | ▲ +17.94% | $6.26 (+19.74%) |
Aug 11, 2026 11w ago | 8-K | $8.04 $7.20 | ▲ +10.45% | ▲ +9.39% | $6.26 (+22.14%) |
Aug 11, 2026 11w ago | Press Release | $8.04 $7.20 | ▲ +10.45% | ▲ +9.39% | $6.26 (+22.14%) |
Jul 8, 2026 15w ago | 8-K | $7.25 $7.18 | ▼ −0.97% | ▼ −4.24% | $6.26 (−13.66%) |
May 19, 2026 22w ago | Press Release | $7.47 $6.34 | ▼ −15.13% | ▼ −15.87% | $6.26 (−16.20%) |
May 5, 2026 24w ago | 8-K | $8.29 $6.88 | ▲ +17.01% | ▲ +19.79% | $6.26 (+24.49%) |
May 5, 2026 24w ago | Press Release | $8.29 $6.88 | ▲ +17.01% | ▲ +19.79% | $6.26 (+24.49%) |
May 4, 2026 25w ago | 8-K | $8.90 $6.90 | ▼ −22.47% | ▼ −27.43% | $6.26 (−29.66%) |
May 4, 2026 25w ago | Press Release | $8.35 $7.19 | ▲ +13.89% | ▲ +19.54% | $6.26 (+25.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers